Fresenius Kabi USA, LLC
Lake Zurich, IL, United States
48
Total Recalls
11
Class I Recalls
1
Ongoing Recalls
Recalls by Fresenius Kabi USA, LLC
FDA Drug
Class I
Ongoing
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
November 6, 2025
Fresenius Kabi USA, LLC
2,199,850 vials units
FDA Drug
Class II
Terminated
Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.5%, 250 mg per 50 mL (5 mg per mL), 50 mL Multiple Dose Vial (NDC 63323-463-01), packaged in
November 22, 2022
Fresenius Kabi USA, LLC
40,025 vials units
FDA Drug
Class II
Terminated
Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 125 mg per 50 mL (2.5 mg per mL), 50 mL Multiple Dose Vial (NDC 63323-461-01), packaged
November 22, 2022
Fresenius Kabi USA, LLC
40,375 vials units
FDA Drug
Class II
Terminated
Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 25 mg per 10 mL (2.5 mg per mL), 10 mL Single Dose Vial (NDC 63323-468-01), packaged
November 22, 2022
Fresenius Kabi USA, LLC
31,600 vials units
FDA Drug
Class I
Terminated
Sodium Acetate Injection, USP, 400 mEq / 100 mL (4 mEq / mL), packaged in 2 trays of 20 vials per shipper (NDC 63323-032-00), each vial: 100 mL fill in a 100 mL vial (NDC 63323-032-04), Rx Only, Frese
March 4, 2022
Fresenius Kabi USA, LLC
118,040 vials units
FDA Drug
Class II
Terminated
Morphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-452-01. 25 vials per tray packaged 18 trays per shipper
September 17, 2021
Fresenius Kabi USA, LLC
963000 vials units
FDA Drug
Class II
Terminated
Xylocaine-MPF with Epinephrine 1:200,000, (Lidocaine HCl and Epinephrine Injection, USP), 1%, 300 mg/30 mL, (10 mg/mL), 30 mL Single Dose Vial, 25 Vials per Tray, Rx only, Fresenius Kabi USA, LLC, Lak
June 25, 2021
Fresenius Kabi USA, LLC
234,800 vials units
FDA Drug
Class I
Terminated
Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL Single Dose Vials per tray (NDC 63323-162-01); For IM or IV use, Rx only, Freseniu
December 23, 2020
Fresenius Kabi USA, LLC
945,425 vials units
FDA Drug
Class II
Terminated
Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-162-02
December 17, 2020
Fresenius Kabi USA, LLC
490,633 vials units
FDA Drug
Class II
Terminated
Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL Single Dose Vial (NDC 63323-462-01), packaged as 25 Single Dose Vials per tray (NDC 63323-
December 10, 2020
Fresenius Kabi USA, LLC
4411 trays units
FDA Drug
Class III
Terminated
DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047. NDC: 63323-883-05
November 17, 2020
Fresenius Kabi USA, LLC
16,986 vials units
FDA Drug
Class I
Terminated
Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-671-05
November 17, 2020
Fresenius Kabi USA, LLC
13,525 bottles units
FDA Drug
Class I
Terminated
Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenous infusion, preservative free, 50 mL Single Dose Bottle, Rx only, Fresenius Kabi Lake Zurich, IL
July 22, 2020
Fresenius Kabi USA, LLC
25,100 bottles units
FDA Drug
Class III
Terminated
Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047; NDC 63323-972-10
July 13, 2020
Fresenius Kabi USA, LLC
63,067 vials units
FDA Drug
Class II
Terminated
Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vials (NDC 63323-162-03), 25 x 2 mL Single Dose Vials per tray (NDC 63323-162-02); For IM use only, N
April 20, 2020
Fresenius Kabi USA, LLC
3,497,575 vials units
FDA Drug
Class I
Terminated
Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL Single Dose Vials per tray (NDC 63323-162-01); For IM or IV use, Rx only, Freseniu
April 20, 2020
Fresenius Kabi USA, LLC
5,314,400 vials units
FDA Drug
Class I
Terminated
Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi, Lake Zurich, IL 60047. 63323-117-61 [Fresenius Kabi brand] and NDC 63323-117-6
June 28, 2019
Fresenius Kabi USA, LLC
14,016 vials units
FDA Drug
Class III
Terminated
Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047, NDC 63323-374-20
May 22, 2019
Fresenius Kabi USA, LLC
11,981 units units
FDA Drug
Class I
Terminated
SODIUM CHLORIDE INJECTION, USP, 0.9%, 10 mL Single Dose Vial, packaged in a 25-unit tray, Rx Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173. NDC 63323-186-10 Product code 918610
November 15, 2018
Fresenius Kabi USA, LLC
23,745,300 10 mL vials units
FDA Drug
Class I
Terminated
SODIUM CHLORIDE INJECTION, USP, 0.9%, 20 mL Single Dose Vial, packaged in a 25-unit tray, Rx Only, APP Pharmaceuticals, LLC Schaumburg, IL 60173. NDC 63323-186-20, Product code 918620
November 15, 2018
Fresenius Kabi USA, LLC
1,312,350 20 mL vials units
FDA Drug
Class III
Terminated
Vecuronium bromide for Injection, 10 mg vials, Rx only, Mfd. for: Fresenius Kabi, Lake Zurich, IL 60047, Made in India, NDC 63323-781-10
January 16, 2018
Fresenius Kabi USA, LLC
35,620 vials units
FDA Drug
Class I
Terminated
Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL), 24 X 2mL Prefilled single-use syringes per carton, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 76045-001-20
October 27, 2017
Fresenius Kabi USA, LLC
203136 syringes units
FDA Drug
Class III
Terminated
Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-0272-05
March 16, 2017
Fresenius Kabi USA, LLC
118,224 vials units
FDA Drug
Class II
Terminated
MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- NDC 63323-412-05
December 16, 2016
Fresenius Kabi USA, LLC
47, 020 vials units
FDA Drug
Class II
Terminated
OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose Vial, Rx only, Manufactured by Fresenius Kabi USA, LLC, Schaumburg, IL 60173, NDC 63323-365-01.
May 4, 2016
Fresenius Kabi USA, LLC
355,150 vials units
FDA Drug
Class II
Terminated
OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose Vial, Rx only, Manufactured by Fresenius Kabi USA, LLC, Schaumburg, IL 60173, NDC 63323-365-04
May 4, 2016
Fresenius Kabi USA, LLC
40,280 vials units
FDA Drug
Class II
Terminated
Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-472-37
April 25, 2016
Fresenius Kabi USA, LLC
69225 units units
FDA Drug
Class III
Terminated
Haloperidol Decanoate Injection, 50 mg/mL, 1 mL vial, Rx Only. Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-469-01.
April 7, 2016
Fresenius Kabi USA, LLC
48,210 units units
FDA Drug
Class II
Terminated
Cisatracurium Besylate Injection, 20 mg per 10 mL (2 mg per mL), For intravenous injection, 10 mL Multiple Dose Vial, Rx only, Fresenius Kabi USA, LLC Lake Zurich, IL 60047, NDC 63323-417-10
April 5, 2016
Fresenius Kabi USA, LLC
94,560 vials units
FDA Drug
Class III
Terminated
Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single dose vial. Manufactured by Fresenius Kabi USA 2020 N Ruby Street, Melrose Park, IL 60160-1112 for Fresenius Kabi USA, 3
July 28, 2015
Fresenius Kabi USA, LLC
93,000 vials units
FDA Drug
Class II
Terminated
Rifampin for Injection, USP 600mg/vial in a 20mL vial, Rx only, Manufactured for Fresenius Kabi LLC 3 Corporate Drive, Lake Zurich, IL, 60047, by Fresenius Kabi LLC, 2020 N Ruby Street, Melrose Park,
June 4, 2015
Fresenius Kabi USA, LLC
7,593 vials units
FDA Drug
Class II
Terminated
KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfite-free], Rx Only. Manufactured by: FRESENIUS KABI Uppsala, Sweden. Packaged in 1) 1,540
April 28, 2015
Fresenius Kabi USA, LLC
5,488 Bags units
FDA Drug
Class II
Terminated
GENTAMICIN INJECTION, USP, equivalent to 40 mg/mL, Rx only, 20 mL Multiple Dose Vial, Manufactured by APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-010-20
November 12, 2014
Fresenius Kabi USA, LLC
92,125 vials units
FDA Drug
Class II
Terminated
PROPRANOLOL HYDROCHLORIDE INJECTION, USP 1 mg/mL, 1 mL Single Dose Vial, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-604-01
August 13, 2014
Fresenius Kabi USA, LLC
56,060 vials units
FDA Drug
Class II
Terminated
Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL), (PE= phenytoin sodium equivalents) 10 mL Single Use Vial, Rx only, Manufactured for APP Fresenius Kabi USA, LLC Lake Zurich, IL 60047
May 2, 2014
Fresenius Kabi USA, LLC
728,880 vials units
FDA Drug
Class II
Terminated
Fosphenytoin Sodium Injection, USP, 100 mg PE/2 mL (50 mg PE/mL) (PE= phenytoin sodium equivalents) 2 mL Single Use Vial, Rx only, Manufactured for APP Fresenius Kabi USA, LLC Lake Zurich, IL 60047,
May 2, 2014
Fresenius Kabi USA, LLC
2,070,500 vials units
FDA Drug
Class III
Terminated
HALOPERIDOL DECANOATE INJECTION, 50 mg/mL, 1 mL vial, Rx only, Fresenius Kabi USA, LLC, Schaumburg, IL 60173 NDC 63323-469-01
April 14, 2014
Fresenius Kabi USA, LLC
216,517 vials units
FDA Drug
Class II
Terminated
Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx only, NDC 63323-540-11, 25 vials in tray, each boxed vial individually labeled a
January 22, 2014
Fresenius Kabi USA, LLC
161,650 vials units
FDA Drug
Class III
Terminated
FOLIC ACID INJECTION, USP; 5 mg/mL ; For IM, IV or SC Use; 10 mL; Multiple Dose Vial; Rx only; APP Pharmaceuticals, LLC; Schaumburg, IL 60173 NDC 63323-184-11
December 6, 2013
Fresenius Kabi USA, LLC
215,340 vials units
FDA Drug
Class III
Terminated
PACLITAXEL INJECTION, USP (semisynthetic); 300 mg/50 mL; (6 mg/mL); Multiple Dose Vial;(NDC 63323-763-50); Rx Only; Manufactured for APP Pharmaceuticals, LLC; Schaumburg, IL 60173; Made in India
November 8, 2013
Fresenius Kabi USA, LLC
71,129 vials units
FDA Drug
Class II
Terminated
Tranexamic Acid Injection USP, 1000mg/10mL, 10mL vial, Rx only. Mfd by: Fresenius Kabi USA, LLC Packaged under two labels: 1) Mfd for: APP Pharmaceuticals, LLC; Schaumburg, IL 60173, NDC 63323-563-
October 31, 2013
Fresenius Kabi USA, LLC
121,456 vials units
FDA Drug
Class II
Terminated
Benztropine Mesylate Injection, USP, 2 mg/2 mL (1 mg/1 mL), 2 mL Single Dose Vial, Rx only, labeled as a) Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-970-02; and b) Man
July 1, 2013
Fresenius Kabi USA, LLC
65110 vials units
FDA Drug
Class II
Terminated
Oxytocin Injection, USP, (Synthetic), 10 USP Units/mL, for IV Infusion or IM Use, Rx Only, 1 mL vial, APP ) 10 USP Units/mL, 1 mL, APP Pharmaceuticals, LLC Schaumburg, IL, 60173, NDC 63323-012-01.
June 24, 2013
Fresenius Kabi USA, LLC
221,600 vials units
FDA Drug
Class I
Terminated
Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50
May 25, 2013
Fresenius Kabi USA, LLC
15,625 vials units
FDA Drug
Class III
Terminated
Folic Acid Injection, USP, 5 mg/mL, For IM, IV or SC Use, 10 mL, Multiple Dose Vial, Rx only, APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-184-11
May 21, 2013
Fresenius Kabi USA, LLC
80,480 vials units
FDA Drug
Class II
Terminated
ONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-373-02
September 27, 2012
Fresenius Kabi USA, LLC
184,550 Vials units
FDA Drug
Class II
Terminated
MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APP Pharmaceuticals, LLC. Schaumburg, IL 60173. NDC: 63323-412-25.
September 27, 2012
Fresenius Kabi USA, LLC
101,200 Vials units
FDA Drug
Class II
Terminated
CYANOCOBALAMIN INJECTION, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-044-01.
September 27, 2012
Fresenius Kabi USA, LLC
240,550 Vials units